TDI01 Suspension in the Treatment of Chronic Graft-versus-host Disease (cGVHD))
Status:
Not yet recruiting
Trial end date:
2027-08-01
Target enrollment:
Participant gender:
Summary
1. Phase Ib study stage:
Primary objective: To evaluate the efficacy and safety Secondary objectives: To evaluate
the population pharmacokinetic characteristics
2. Phase II study stage:
Primary objective: To evaluate the efficacy Secondary objectives: To evaluate the safety